Below you find a list of LEO Pharma's most recent press releases. The press releases are only intended for use by journalists.
14-09-2017 LEO Pharma announces more than half of patients on Kyntheum® (brodalumab) maintain consistent levels of complete skin clearance for more than two years
22-06-2017 Partnership Agreement for a Gel Formulation of betamethasone dipropionate in Japan: Treatment for Psoriasis Vulgaris
21-06-2017 LEO Pharma invests in Novopyxis to develop an aerosol-based drug delivery device for topical treatments
30-05-2017 Almirall and LEO Pharma join forces to advance dermatology research by setting a new standard for skin sampling
03-03-2017 LEO Pharma announces positive results from phase 2b clinical study for tralokinumab in atopic dermatitis.
11-10-2016 LEO Pharma announces restructuring plans to streamline its organisation and support new portfolio
30-09-2016 LEO Pharma announces collaboration with Washington University to enhance understanding of atopic dermatitis
13-09-2016 LEO Pharma strengthens global leadership to accelerate entry into biologics in dermatology
15-08-2016 LEO Pharma Research Foundation awards two promising and talented scientists in skin research
24-06-2016 LEO Pharma strengthens Board of Directors